Oncology: from biotechnologies a further weapon

According to the Health World Organization the study of a vaccine against the uterus cervix tumours, pathology affecting half a million women per year, is in an advanced phase. The news is such to give a point in favour of the genetic engineering, thanks to which it has been elaborated the substances for the next vaccine. Indeed biotechnologies go on rising polemics, but the drugs deriving from them are already the 5% of the world market.